3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Status
Active not recruiting
34
Completed
20
Recruiting
19
Terminated
10
Withdrawn
2
Not yet recruiting
1
Approved for marketing
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Genitourinary
2
Conditions
Prostatic Neoplasms
1
Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
1
Interventions
pembrolizumab
19
Magnetic Resonance Spectroscopy
13
Specimen Handling
12
Cyclophosphamide
10
fludarabine
9
Radiotherapy
9
Biopsy
8
atezolizumab
7
Nivolumab
7
Radiation
6
Prednisone
4
Gemcitabine
4
Etoposide
4
Cytarabine
4
Cisplatin
4
Carboplatin
4
Blood Specimen Collection
4
ALT-803
4
lenvatinib
3
fludarabine phosphate
3
avelumab
3
aldesleukin
3
X-Rays
3
Vincristine
3
Surveys and Questionnaires
3
Rituximab
3
Phantoms, Imaging
3
Paclitaxel
3
Oxaliplatin
3
Lenalidomide
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Withdrawn
×
niraparib
×
1 year
×
Clear all
NCT06392841
2026-04-08
HARMONY
Hoosier Cancer Research Network
Phase 2
Withdrawn
NCT06527690
2025-09-29
REPRESENTATION
Latin American Cooperative Oncology Group
Phase 2
Withdrawn